Evidence map›Paper›PMID 31390174›Full record

ReviewAccounts of chemical research2019

Development and Application of Carbonyl Sulfide-Based Donors for H

Carolyn M Levinn, Matthew M Cerda, Michael D Pluth

Open access · greenAbstract readReview
In one paragraph

Review in Accounts of chemical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Photorelease of Hydrogen Sulfide (HThe Journal of organic chemistry · 2025
    Article
  6. Article
  7. Article
  8. Thio-ProTide strategy: A novel HActa pharmaceutica Sinica. B · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Fluorescent small molecule donors.Chemical Society reviews · 2024
    Review
  13. Review
  14. Review
  15. Enzyme-Triggered Chemodynamic Therapy via a Peptide-HAngewandte Chemie (International ed. in English) · 2023
    Article
  16. HAntioxidants (Basel, Switzerland) · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Carolyn M LevinnDepartment of Chemistry and Biochemistry, Materials Science Institute, Institute of Molecular Biology , University of Oregon , Eugene , Oregon 97403 , United States.ORCID 0000-0001-7857-7465
Matthew M CerdaDepartment of Chemistry and Biochemistry, Materials Science Institute, Institute of Molecular Biology , University of Oregon , Eugene , Oregon 97403 , United States.ORCID 0000-0002-5401-6169
Michael D PluthDepartment of Chemistry and Biochemistry, Materials Science Institute, Institute of Molecular Biology , University of Oregon , Eugene , Oregon 97403 , United States.ORCID 0000-0003-3604-653X
University of Oregon · US

Funding

Supplement to: Chemical Tools for Delivery and Detection of Biological Hydrogen SulfideR01GM113030 · NIGMS · UNIVERSITY OF OREGON · PI PLUTH, MICHAEL · 2015 to 2024
$2.8M
NIGMS NIH HHS R01 GM113030
6 · The paper itself

Abstract

In addition to nitric oxide and carbon monoxide, hydrogen sulfide (H

Indexed as

AnimalsCarbonic AnhydrasesCell SurvivalHeLa CellsHumansHydrogen PeroxideHydrogen SulfideMiceMolecular StructureRAW 264.7 CellsSulfur OxidesThiocarbamatesCarbonic Anhydrasescarbonyl sulfideHydrogen PeroxideHydrogen SulfideSulfur OxidesThiocarbamates

Identifiers

PMID31390174
PMCPMC7047812
OpenAlexW2965101300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.